HDL Cholesterol Efflux Capacity in Newly Diagnosed HIV and Effects of Antiretroviral Therapy.

about

Cholesterol efflux responds to viral load and CD4 counts in HIV+ patients and is dampened in HIV exposed

P2860

Q58741972-DC682DFD-A858-43AE-A0B0-97CB9F719BD9

P2860

HDL Cholesterol Efflux Capacity in Newly Diagnosed HIV and Effects of Antiretroviral Therapy.

Item

http://www.wikidata.org/entity/Q46224865

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

HDL Cholesterol Efflux Capacit ...... cts of Antiretroviral Therapy.

@en

HDL Cholesterol Efflux Capacit ...... cts of Antiretroviral Therapy.

@nl

type

Item

label

HDL Cholesterol Efflux Capacit ...... cts of Antiretroviral Therapy.

@en

HDL Cholesterol Efflux Capacit ...... cts of Antiretroviral Therapy.

@nl

prefLabel

HDL Cholesterol Efflux Capacit ...... cts of Antiretroviral Therapy.

@en

HDL Cholesterol Efflux Capacit ...... cts of Antiretroviral Therapy.

@nl

P1476

HDL Cholesterol Efflux Capacit ...... cts of Antiretroviral Therapy.

@en

P2093

Gregory K Robbins

http://www.w3.org/2001/XMLSchema#string

Kathleen Melbourne

http://www.w3.org/2001/XMLSchema#string

Kenneth C Williams

http://www.w3.org/2001/XMLSchema#string

Lauren Stone

http://www.w3.org/2001/XMLSchema#string

Mabel Toribio

http://www.w3.org/2001/XMLSchema#string

Markella V Zanni

http://www.w3.org/2001/XMLSchema#string

Meghan N Feldpausch

http://www.w3.org/2001/XMLSchema#string

Michael L Fitzgerald

http://www.w3.org/2001/XMLSchema#string

Min Hi Park

http://www.w3.org/2001/XMLSchema#string

Steven K Grinspoon

http://www.w3.org/2001/XMLSchema#string

P2860

Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine

HIV infection and the risk of acute myocardial infarction.

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.

Phenotype, function, and differentiation potential of human monocyte subsets.

Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection.

Treatment of HIV infection with a raltegravir-based regimen increases LDL levels, but improves HDL cholesterol efflux capacity.

Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.

Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection.

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

Sex differences in lipid and lipoprotein metabolism: it's not just about sex hormones.

P304

4250-4259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2017-01334

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28945911

http://www.w3.org/2001/XMLSchema#string

P932

5673269

http://www.w3.org/2001/XMLSchema#string

HDL Cholesterol Efflux Capacity in Newly Diagnosed HIV and Effects of Antiretroviral Therapy.

about

P2860

P2860

HDL Cholesterol Efflux Capacity in Newly Diagnosed HIV and Effects of Antiretroviral Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932